annual CFO:
-$455.57M-$131.34M(-40.51%)Summary
- As of today (June 2, 2025), MDGL annual cash flow from operations is -$455.57 million, with the most recent change of -$131.34 million (-40.51%) on December 31, 2024.
- During the last 3 years, MDGL annual CFO has fallen by -$271.65 million (-147.71%).
- MDGL annual CFO is now -1773.54% below its all-time high of $27.22 million, reached on December 31, 2007.
Performance
MDGL Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$88.89M+$15.60M(+14.93%)Summary
- As of today (June 2, 2025), MDGL quarterly cash flow from operations is -$88.89 million, with the most recent change of +$15.60 million (+14.93%) on March 31, 2025.
- Over the past year, MDGL quarterly CFO has increased by +$60.27 million (+40.40%).
- MDGL quarterly CFO is now -230.01% below its all-time high of $68.37 million, reached on December 31, 2007.
Performance
MDGL quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$395.31M+$60.27M(+13.23%)Summary
- As of today (June 2, 2025), MDGL TTM cash flow from operations is -$395.31 million, with the most recent change of +$60.27 million (+13.23%) on March 31, 2025.
- Over the past year, MDGL TTM CFO has dropped by -$5.99 million (-1.54%).
- MDGL TTM CFO is now -1405.58% below its all-time high of $30.28 million, reached on June 30, 2016.
Performance
MDGL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
MDGL Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -40.5% | +40.4% | -1.5% |
| 3 y3 years | -147.7% | -78.1% | -107.6% |
| 5 y5 years | -994.5% | -191.4% | -502.1% |
MDGL Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -147.7% | at low | -78.1% | +40.4% | -107.6% | +13.2% |
| 5 y | 5-year | -994.5% | at low | -266.4% | +40.4% | -502.1% | +13.2% |
| alltime | all time | -1773.5% | at low | -230.0% | +40.4% | -1405.6% | +13.2% |
MDGL Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$88.89M(-14.9%) | -$395.31M(-13.2%) |
| Dec 2024 | -$455.57M(+40.5%) | -$104.49M(+56.0%) | -$455.57M(+5.7%) |
| Sep 2024 | - | -$66.98M(-50.4%) | -$431.02M(-4.0%) |
| Jun 2024 | - | -$134.94M(-9.5%) | -$448.95M(+15.3%) |
| Mar 2024 | - | -$149.16M(+86.6%) | -$389.32M(+20.1%) |
| Dec 2023 | -$324.23M(+44.2%) | -$79.93M(-5.9%) | -$324.23M(+7.1%) |
| Sep 2023 | - | -$84.92M(+12.8%) | -$302.81M(+9.3%) |
| Jun 2023 | - | -$75.31M(-10.4%) | -$276.96M(+6.9%) |
| Mar 2023 | - | -$84.07M(+43.7%) | -$259.01M(+15.2%) |
| Dec 2022 | -$224.86M(+22.3%) | -$58.52M(-0.9%) | -$224.86M(+4.9%) |
| Sep 2022 | - | -$59.07M(+3.0%) | -$214.39M(+6.7%) |
| Jun 2022 | - | -$57.36M(+14.9%) | -$200.88M(+5.5%) |
| Mar 2022 | - | -$49.91M(+3.9%) | -$190.40M(+3.5%) |
| Dec 2021 | -$183.92M(+16.7%) | -$48.05M(+5.5%) | -$183.92M(-3.6%) |
| Sep 2021 | - | -$45.56M(-2.8%) | -$190.81M(-1.2%) |
| Jun 2021 | - | -$46.88M(+7.9%) | -$193.11M(+13.3%) |
| Mar 2021 | - | -$43.43M(-21.0%) | -$170.48M(+8.2%) |
| Dec 2020 | -$157.56M(+278.5%) | -$54.95M(+14.8%) | -$157.56M(+37.1%) |
| Sep 2020 | - | -$47.85M(+97.3%) | -$114.90M(+46.6%) |
| Jun 2020 | - | -$24.26M(-20.5%) | -$78.37M(+19.4%) |
| Mar 2020 | - | -$30.51M(+148.4%) | -$65.65M(+57.7%) |
| Dec 2019 | -$41.62M(+63.2%) | -$12.28M(+8.5%) | -$41.62M(+16.9%) |
| Sep 2019 | - | -$11.32M(-1.9%) | -$35.61M(+20.6%) |
| Jun 2019 | - | -$11.54M(+78.1%) | -$29.52M(+26.5%) |
| Mar 2019 | - | -$6.48M(+3.4%) | -$23.34M(-8.5%) |
| Dec 2018 | -$25.51M(+14.3%) | -$6.26M(+19.6%) | -$25.51M(+1.3%) |
| Sep 2018 | - | -$5.24M(-2.3%) | -$25.19M(+1.2%) |
| Jun 2018 | - | -$5.36M(-38.0%) | -$24.90M(-8.4%) |
| Mar 2018 | - | -$8.64M(+45.4%) | -$27.19M(+21.8%) |
| Dec 2017 | -$22.32M(+26.7%) | -$5.95M(+20.1%) | -$22.32M(+3.1%) |
| Sep 2017 | - | -$4.95M(-35.3%) | -$21.65M(-16.5%) |
| Jun 2017 | - | -$7.65M(+102.9%) | -$25.94M(+23.9%) |
| Mar 2017 | - | -$3.77M(-28.6%) | -$20.94M(+18.9%) |
| Dec 2016 | -$17.61M(+460.4%) | -$5.28M(-42.9%) | -$17.61M(+31.2%) |
| Sep 2016 | - | -$9.24M(+249.2%) | -$13.42M(-144.3%) |
| Jun 2016 | - | -$2.65M(+504.3%) | $30.28M(+99.3%) |
| Mar 2016 | - | -$438.00K(-60.0%) | $15.20M(-583.6%) |
| Dec 2015 | -$3.14M | -$1.10M(-103.2%) | -$3.14M(-85.2%) |
| Sep 2015 | - | $34.46M(-294.4%) | -$21.26M(-71.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2015 | - | -$17.73M(-5.6%) | -$74.29M(-4.1%) |
| Mar 2015 | - | -$18.77M(-2.3%) | -$77.43M(-1.9%) |
| Dec 2014 | -$78.92M(+2.0%) | -$19.21M(+3.5%) | -$78.92M(+0.7%) |
| Sep 2014 | - | -$18.57M(-11.1%) | -$78.40M(+2.6%) |
| Jun 2014 | - | -$20.87M(+3.0%) | -$76.42M(+1.3%) |
| Mar 2014 | - | -$20.27M(+8.5%) | -$75.47M(-2.5%) |
| Dec 2013 | -$77.41M(+43.0%) | -$18.69M(+12.7%) | -$77.41M(+8.7%) |
| Sep 2013 | - | -$16.59M(-16.7%) | -$71.24M(+4.9%) |
| Jun 2013 | - | -$19.92M(-10.3%) | -$67.92M(+11.2%) |
| Mar 2013 | - | -$22.21M(+77.4%) | -$61.09M(+12.9%) |
| Dec 2012 | -$54.13M(+14.5%) | -$12.52M(-5.6%) | -$54.13M(+3.9%) |
| Sep 2012 | - | -$13.26M(+1.3%) | -$52.10M(+2.8%) |
| Jun 2012 | - | -$13.10M(-14.2%) | -$50.66M(+1.9%) |
| Mar 2012 | - | -$15.25M(+45.5%) | -$49.72M(+5.1%) |
| Dec 2011 | -$47.30M(+23.8%) | -$10.49M(-11.3%) | -$47.30M(+5.1%) |
| Sep 2011 | - | -$11.82M(-2.7%) | -$45.03M(+8.2%) |
| Jun 2011 | - | -$12.15M(-5.3%) | -$41.63M(+8.3%) |
| Mar 2011 | - | -$12.84M(+56.3%) | -$38.45M(+0.7%) |
| Dec 2010 | -$38.20M(+42.5%) | -$8.21M(-2.5%) | -$38.20M(+2.5%) |
| Sep 2010 | - | -$8.43M(-6.1%) | -$37.25M(+0.5%) |
| Jun 2010 | - | -$8.97M(-28.7%) | -$37.08M(-28.2%) |
| Mar 2010 | - | -$12.59M(+73.3%) | -$51.63M(+92.6%) |
| Dec 2009 | -$26.81M(-29.3%) | -$7.26M(-11.9%) | -$26.81M(+795.8%) |
| Sep 2009 | - | -$8.25M(-64.9%) | -$2.99M(-79.5%) |
| Jun 2009 | - | -$23.52M(-292.4%) | -$14.57M(+45.8%) |
| Mar 2009 | - | $12.23M(-26.1%) | -$9.99M(-73.7%) |
| Dec 2008 | -$37.94M(-239.4%) | $16.55M(-183.5%) | -$37.94M(-373.3%) |
| Sep 2008 | - | -$19.83M(+4.7%) | $13.88M(-24.2%) |
| Jun 2008 | - | -$18.94M(+20.5%) | $18.31M(-25.8%) |
| Mar 2008 | - | -$15.72M(-123.0%) | $24.68M(-9.3%) |
| Dec 2007 | $27.22M(-151.4%) | $68.37M(-543.8%) | $27.22M(-166.2%) |
| Sep 2007 | - | -$15.41M(+22.6%) | -$41.15M(+59.8%) |
| Jun 2007 | - | -$12.57M(-4.6%) | -$25.75M(+95.4%) |
| Mar 2007 | - | -$13.18M(-1.4%) | -$13.18M(-1.4%) |
| Dec 2006 | -$52.98M(-14.4%) | - | - |
| Dec 2005 | -$61.88M(+83.1%) | - | - |
| Mar 2005 | - | -$13.37M | -$13.37M |
| Dec 2004 | -$33.80M(+43.1%) | - | - |
| Dec 2003 | -$23.61M | - | - |
FAQ
- What is Madrigal Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual CFO year-on-year change?
- What is Madrigal Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly CFO year-on-year change?
- What is Madrigal Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals TTM CFO year-on-year change?
What is Madrigal Pharmaceuticals annual cash flow from operations?
The current annual CFO of MDGL is -$455.57M
What is the all time high annual CFO for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual cash flow from operations is $27.22M
What is Madrigal Pharmaceuticals annual CFO year-on-year change?
Over the past year, MDGL annual cash flow from operations has changed by -$131.34M (-40.51%)
What is Madrigal Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of MDGL is -$88.89M
What is the all time high quarterly CFO for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly cash flow from operations is $68.37M
What is Madrigal Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, MDGL quarterly cash flow from operations has changed by +$60.27M (+40.40%)
What is Madrigal Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of MDGL is -$395.31M
What is the all time high TTM CFO for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high TTM cash flow from operations is $30.28M
What is Madrigal Pharmaceuticals TTM CFO year-on-year change?
Over the past year, MDGL TTM cash flow from operations has changed by -$5.99M (-1.54%)